Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 12.68
-0.29 (-2.24%)
Sep 2, 2026, 3:00 PM CST
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 6.02 billion as of September 1, 2026. Its market cap has decreased by -29.43% in one year.
Market Cap
6.02B
Enterprise Value
4.18B
Revenue
836.28M
Ranking
n/a
PE Ratio
19.08
Stock Price
12.68
ChartMarket Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 6.02B, a decrease of -59.03%. That is a compound annual growth rate of -13.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 6.02B | -15.01% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 6.81B |
| Jiangsu Aidea Pharmaceutical Group | 6.78B |
| Zhejiang Ausun Pharmaceutical | 6.63B |
| Youcare Pharmaceutical Group | 6.34B |
| Novogene | 6.29B |
| PharmaResources (Shanghai) | 5.53B |
| Hangzhou Biotest Biotech | 5.41B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.20B |